-
Analyst Opinions
NewOnline Gambling in Greater China – Patent and Company Insights, Key Trends and Challenges
Online Gambling in Greater China Report Overview In Greater China, the trends in online gambling patents showcase innovative advancements, particularly focusing on enhancing user experience through the integration of virtual reality (VR) and Internet of Things (IoT) technologies. Additionally, these patents aim to improve operational efficiency within lotteries while ensuring fair play and security through the implementation of blockchain technology and advanced ticketing systems. The ’Online Gambling in Greater China’ research report dives into the key patent trends and active...
-
Product Insights
NewInnovations in Patent Foramen Ovale Closure Devices – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Patent Foramen Ovale Closure Devices - Global Pipeline Summary" provides comprehensive information about the Patent Foramen Ovale Closure Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Patent Foramen Ovale Closure Devices report provides key information and data related to: Extensive coverage of the Patent Foramen Ovale Closure Devices under development Review details of major pipeline products which include...
-
Track & Monitor
NewInnovation in power: nuclear reactor cooling systems
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the power industry’s nuclear reactor cooling systems segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Sector Analysis
NewFuture of Pharma – Looking Ahead to 2024
This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and market-based analysis, allowing you to discern the large-scale changes and how best to pivot and prioritize them within your sectors.
-
Product Insights
NewProstaglandin G/H Synthase 1 – Drugs In Development, 2024
The Prostaglandin G/H Synthase 1 pipeline drugs market research report outlays comprehensive information on the Prostaglandin G/H Synthase 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Immunology, Musculoskeletal Disorders, and Cardiovascular which include indications of Pain, Post-Operative Pain, Inflammation, Rheumatoid Arthritis, Osteoarthritis, Muscle Spasm, Patent Ductus Arteriosus, and Myocardial Infarction. It also reviews...
-
Product Insights
NewNet Present Value Model: Sanofi’s INBRX-101
Empower your strategies with our Net Present Value Model: Sanofi's INBRX-101 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence. emphysema. The therapeutic candidate comprises of alpha-1 antitrypsin (AAT)-Fc fusion proteins and developed based...
-
Product Insights
NewNet Present Value Model: Inhibrx Inc’s INBRX-101
Empower your strategies with our Net Present Value Model: Inhibrx Inc's INBRX-101 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence. emphysema. The therapeutic candidate comprises of alpha-1 antitrypsin (AAT)-Fc fusion proteins and developed...
-
Thematic Analysis
NewSocial Media in Sport – Thematic Intelligence
An analysis of social media in sport which provides a detailed, yet easy to follow overview of a very important topic in the sport industry. The report will take a look at the key leaders in the industry and a detailed analysis of the social media in sport value chain. Social media’s ad-funded business model is under threat Social media companies will increasingly diversify away from their ad-funded business model in the face of increased regulatory scrutiny. In 2023 alone,...
-
Track & Monitor
NewArtificial Intelligence in Retail: Planogram modelling
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the retail industry’s Planogram modelling segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gemcitabine Hydrochloride in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gemcitabine Hydrochloride in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gemcitabine Hydrochloride in Pancreatic Cancer Drug Details: RenovoGem is under...